Explore chapters and articles related to this topic
A New Perspective Into Affordable, Quality Healthcare: The Case of Pronto Care
Published in Frederick J. DeMicco, Ali A. Poorani, Medical Travel Brand Management, 2023
Adel Eldin, Frederick J. DeMicco
The list of anti-inflammatory food would include green-leafy vegetables, Chinese cabbage, beets, broccoli, blueberries, pineapple, salmon, walnuts, flax seeds, chia seeds, turmeric, and ginger. Food deserts are characterized by residents who have little to no access to transportation, communities of color, low-income communities, communities that are highly saturated with liquor stores and fast-food outlets which serve high sugar, high salt, and/or high carbohydrate and processed food(s).
Herbs in Health Management
Published in Raj K. Keservani, Anil K. Sharma, Rajesh K. Kesharwani, Nutraceuticals and Dietary Supplements, 2020
Cardamom like ginger and turmeric has good anti-inflammatory properties. The powder of cardamom seeds can be used to treat inflammation of the mouth, mucus membranes, and throat (Gadekar and Jadhav, 2017).
Heterocyclic Drug Design and Development
Published in Rohit Dutt, Anil K. Sharma, Raj K. Keservani, Vandana Garg, Promising Drug Molecules of Natural Origin, 2020
Garima Verma, Mohammad Shaquiquzzaman, Mohammad Mumtaz Alam
Pain is a distressing condition produced in response to some intense or damaging stimuli. In order to get relief from pain, a group of drugs known as analgesics is employed. They produce analgesia by acting on peripheral and central nervous systems. Nonsteroidal anti-inflammatory drugs (NSAIDs) are most frequently used. Certain analgesics procured from plants are mentioned in Table 9.21.
Intermediate Uveitis: A Review
Published in Ocular Immunology and Inflammation, 2023
Andrea York Tiang Teo, Bjorn Kaijun Betzler, Keith Low Qie Hua, Elizabeth Jiahui Chen, Vishali Gupta, Rupesh Agrawal
If an underlying cause of intermediate uveitis is found, treatment of IU is directed at the cause. It is imperative to rule out infection and malignancy before starting the patient on anti-inflammatory therapy. Even if no cause is detected, treatment is not required for all patients, such as in those with mild disease who retain good vision with no associated complications. However, if treatment is indicated, a stepladder approach, first introduced by Kaplan,174 and more recently espoused by Foster et al.,175 is commonly adopted in the management of IU. Corticosteroids are the mainstay of treatment, failing which conventional immunosuppressants may be used. While laser and cryopexy have been indicated as the third step of therapy,175 the risk of rupturing the blood-retinal barrier in surgical interventions, and increasing evidence of the safety and efficacy of biologic therapies and have prompted increased acceptance of biologics in the treatment of IU.176–178 Finally, pars plana vitrectomy may be used in cases of IU with sight-threatening complications. The aim of treatment is to completely suppress the intraocular inflammation.
Preparation and in vitro–in vivo evaluation of QbD based acemetacin loaded transdermal patch formulations for rheumatic diseases
Published in Pharmaceutical Development and Technology, 2022
Ece Özcan Bülbül, Hasan Ali Husseın, Gizem Yeğen, Mehmet Evren Okur, Neslihan Üstündağ Okur, Neşe Buket Aksu
Acemetacin is an anti-inflammatory and non-steroidal drug (NSAID) used for rheumatic diseases. The daily dosage of acemetacin is 120 mg p.o. (can be increased to 180 mg) and plasma half-life of 1–2 h. The most common adverse effects are peptic ulceration or gastrointestinal bleeding (Chandrasekharan 2007). Orally administered anti-inflammatory non-steroidal drugs also cause side effects like vomiting, nausea, abdominal pain, dizziness, heartburn, and headache (Amodwala et al. 2017). The most frequent indications are chronic articular rheumatism, psoriatic arthritis, and acute inflammatory events in degenerative arthropathies. Nowadays, capsule (extended-release, delayed-release, and coated) dosage form is available. However, a transdermal system can help overcome the adverse effects (Li et al. 2005). By preparing the transdermal system of acetametacin, it is aimed at circulating at a certain speed and delivering the drug through the skin in a controlled manner. In addition, TDDS was preferred over the oral route because it has advantages, including increased patient compliance and avoidance of first-pass metabolism (Sabbagh and Kim 2022).
Chronic Recurrent Multifocal Osteomyelitis (CRMO): A Study of 12 Cases from One Institution and Literature Review
Published in Fetal and Pediatric Pathology, 2022
Eric Chang, Jasmine Vickery, Nadeen Zaiat, Eman Sallam, Abdul Hanan, Scott Baker, Mohamed Alhamar, Janet Poulik, Ereny Demian, Bahig M Shehata
Nonsteroidal anti-inflammatory drugs (NSAIDs) are considered the first-line treatment. Treatment typically consists of prescribing the usual anti-inflammatory dose for 4 weeks before deeming the disease as not responding [12]. A large study in Europe demonstrated when patients are treated with NSAIDs, a 39% remission rate was seen and 52% of the cases had a partial response [6]. Indomethacin has achieved a clinical and radiological improvement of lesions and absolute normalization of bone lesions in some cases [13]. When the spine is affected, bisphosphonates have exhibited a significant role in pain relief, controlling inflammation, and bone remodeling. They are often used in this setting to prevent further compression and allow mild recovery of the spinal column height [4,8].